Patents by Inventor Kentaro MATSUURA

Kentaro MATSUURA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11953924
    Abstract: In order to prevent unnatural behavior of a calculated flow rate, provided is a fluid control device in which a fluid control valve and upstream and downstream pressure sensors are provided on a flow path. The device includes a calculation unit configured to calculate a flow rate based on measured pressures; and an output unit configured to output the calculated flow rate, and exhibit a zero output function of outputting a zero value regardless of the calculated flow rate when the valve is in a closed state. The device is further configured to switch between execution and stop of the zero output function, and when the valve is in an open state and a difference between the measured pressures of the pressure sensors is larger than a threshold, stop the zero output function and cause the flow rate output unit to output the calculated flow rate.
    Type: Grant
    Filed: June 23, 2022
    Date of Patent: April 9, 2024
    Assignee: HORIBA STEC, Co., Ltd.
    Inventors: Sota Matsumoto, Kentaro Nagai, Yosuke Hisamori, Kazuhiro Matsuura
  • Patent number: 10907216
    Abstract: The present invention addresses the problem of how to provide a predictive marker useful for carcinogenesis surveillance after hepatitis C virus eradication. Provided is a predictive marker composed of a single nucleotide polymorphism specified by rs17047200. In the present invention, the single nucleotide polymorphism is detected in nucleic acid samples collected from subjects, thereby to examine the risk of developing hepatocellular carcinoma after of hepatitis C virus eradication.
    Type: Grant
    Filed: March 31, 2017
    Date of Patent: February 2, 2021
    Assignee: PUBLIC UNIVERSITY CORPORATION NAGOYA CITY UNIVERSITY
    Inventors: Yasuhito Tanaka, Kentaro Matsuura
  • Patent number: 10695392
    Abstract: Disclosed embodiments provide a method of improving systemic symptoms such as sensitivity to cold via an oral composition. The oral composition includes, as its effective component, a red vine leaf extract to improve a symptom selected from the group consisting of sensitivity to cold, general fatigue, general weariness, stiff shoulders, and neck stiffness.
    Type: Grant
    Filed: May 22, 2015
    Date of Patent: June 30, 2020
    Assignee: SSP CO. LTD
    Inventors: Kentaro Matsuura, Ichiro Kawase, Atsushi Sawamura
  • Publication number: 20190093173
    Abstract: The present invention addresses the problem of how to provide a predictive marker useful for carcinogenesis surveillance after hepatitis C virus eradication. Provided is a predictive marker composed of a single nucleotide polymorphism specified by rs17047200. In the present invention, the single nucleotide polymorphism is detected in nucleic acid samples collected from subjects, thereby to examine the risk of developing hepatocellular carcinoma after of hepatitis C virus eradication.
    Type: Application
    Filed: March 31, 2017
    Publication date: March 28, 2019
    Inventors: Yasuhito Tanaka, Kentaro Matsuura
  • Publication number: 20170202899
    Abstract: Disclosed embodiments provide a method of improving systemic symptoms such as sensitivity to cold via an oral composition. The oral composition includes, as its effective component, a red vine leaf extract to improve a symptom selected from the group consisting of sensitivity to cold, general fatigue, general weariness, stiff shoulders, and neck stiffness.
    Type: Application
    Filed: May 22, 2015
    Publication date: July 20, 2017
    Applicant: SSP CO. LTD
    Inventors: Kentaro MATSUURA, Ichiro KAWASE, Atsushi SAWAMURA